Micro RNAs in the development of non-alcoholic fatty liver disease

Table 3 Changes in circulating miRNAs associated with nonalcoholic fatty liver disease in humans

Population	Study design	Source of miRNA	miRNAs	Effect	Ref.
NAFLD	Mild vs Severe steaosis; Severe vs Mild fibrosis	Serum	miR-122	Decrease	[35]
NAFLD	NAFLD vs normal	Serum	miR-122, miR-34a, miR-16, and miR-21	Increased	[36]
NAFLD	NAFLD vs normal	Serum	miR-15b	Increased	[19]
NAFLD	NAFLD vs normal	Serum	miR-122, miR-192, miR-19a, miR-19b, miR-125b, and miR-375	Increased	[37]

NAFLD: Nonalcoholic fatty liver disease.